B cells inhibit induction of T cell-dependent tumor immunity

Nature Medicine

Volumn 4, Issue 5, 1998, Pages 627-630

  Qin, Zhihai ^b   Richter, Günther ^b   Schüler, Thomas ^b   Ibe, Sabrina ^b   Cao, Xuetao ^a   Blankenstein, Thomas ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, NEOPLASM; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, MUTANT STRAINS; T-LYMPHOCYTES;

ANIMALIA;

EID: 0031863680     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0598-627     Document Type: Article

References (35)

1. Ellenhorn, J. D. I., Schreiber, H. & Bluestone, J. A. Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated mice. J. Immunol. 144, 2840-2846 (1990).
2. Cavallo, F. et al. Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J. Immunol. 149, 3627-3635 (1992).
3. Lanzavecchia, A. Antigen-specific interaction between T and B cells. Nature 314, 537-539 (1985).
4. Ron, Y. & Sprent, J. T cell priming in vivo: A major role for B cells in presenting antigen to T cells in lymph nodes. J. Immunol. 138, 2848-2856 (1987).
5. Janeway, Jr., C. A., Ron, J. & Katz, M. E. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J. Immunol. 138, 1051-1055 (1987).
6. Ashwell, J. D. Are B lymphocytes the principal antigen-presenting cells in vivo? J. Immunol. 140, 3697-3700 (1988).
7. Fuchs, E. J. & Matzinger, P. B cells turn off virgin but not memory T cells. Science 258, 1156-1159 (1992).
8. Eynon, E. E. & Parker, D. C. Small B cell as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175, 131-138 (1992).
9. Constant, S. et al. Peptide and protein antigens require distinct antigen-presenting cell subsets for the priming of CD4+ T cells. J. Immunol. 154, 4915-4923 (1995).
10. Simitsek, P. D., Campbell, D. G., Lanzavecchia, A., Fairweather, N. & Watts, C. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. Exp. Med. 181, 1957-1963 (1995).
11. Saoudi, A., Simmonds, S., Huitinga, I. & Mason, D. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. J. Exp. Med. 182, 335-344 (1995).
12. Stockinger, B., Zal, T., Zal, A. & Gray, D. B cells solicit their own help from T cells. J. Exp. Med. 183, 891-899 (1996).
13. Macaulay, A. E., DeKruyff, R. H. & Umetsu, D. T. Antigen-primed T cells from B cell-deficient JHD mice fail to provide B cell help. J. Immunol. 160, 1694-1700 (1998).
14. Kitamura, D., Roes, J., Kuhn, R. & Rajewsky, K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350, 423-426 (1991).
15. Epstein, M. M., Rosa, F. D., Jankovic, D., Sher, A. & Matzinger, P. Successful T cell priming in B cell-deficient mice. J. Exp. Med. 182, 915-922 (1995).
16. Vella, A. T., Scherer, M. T., Shultz, L., Kappler, J. W. & Marrack, P. B cells are not essential for peripheral T-cell tolerance. Proc. Natl. Acad. Sci. USA 93, 951-955 (1996).
17. + T cell activation and tolerance induction in B cell knockout mice. J. Exp. Med. 183, 1339-1344 (1996).
18. Asano, M. S. & Ahmed, R. CD8 T cell memory in B cell-deficient mice. J. Exp. Med. 183, 2165-2174 (1996).
19. Di Rosa, F. & Matzinger, P. Long-lasting CD8 T cell memory in the absence of CD4 T cells or B cells. J. Exp. Med. 183, 2153-2163 (1996).
20. Disis, M. L. & Cheever, M. A. Oncogenic proteins as tumor antigens. Curr. Opin. Immunol. 8, 637-642 (1996).
21. Schreiber, H. Tumor Immunology. In: Fundamental Immunol. 3rd edn. (ed. W. E. Paul) pp 1143-1178, Raven, New York, (1993).
22. Blankenstein, T., Cayeux, S. & Qin, Z. Genetic approaches to cancer immunotherapy. Rev. Phys. Biochem. Pharmacol. 129, 1-49 (1996).
23. Huang, A. Y. et al. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264, 961-965 (1994).
24. Cayeux, S. et al. Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation. J. Immunol. 158, 2834-2842 (1997).
25. Lubin, R. et al. Serum p53 antibodies as early markers of lung cancer. Nat. Med. 1, 701-702 (1995).
26. Houbiers, J. G. A. et al. Antibodies against p53 are associated with poor prognosis of colorectal cancer. Brit. J. Cancer 72, 637-641 (1995).
27. Feldman, J. D. Immunological enhancement: a study of blocking antibodies. Adv. Immunol. 15, 167-214 (1972).
28. Rowley, D. A. & Stach, R. M. A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens. J. Exp. Med. 178, 835-840 (1993).
29. Gajewski, T. F., Pinnas, M., Wong, T. & Fitch, F. W. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J. Immunol. 146, 1750-1758 (1991).
30. Awwad, M. & North, R. J. Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity. J. Exp. Med. 168, 2193-2206 (1988).
31. Monach, P. A., Schreiber, H. & Rowley, D. A. CD4+ and B lymphocytes in transplantation immunity. II. Augmented rejection of tumor allografts by mice lacking B cells. Transplantation 55 1356-1361 (1993).
32. Steinman, R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271-296 (1991).
33. Schultz, K. R., Klarnet, J. P., Gieni, R. S., Hayglass, K. T. & Greenberg, P. D. The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia. Science 249, 921-923 (1990).
34. Prehn, R. T. Perspectives on oncogenesis: does immunity stimulate or inhibit neoplasia? J. Reticulo. Soc. 10, 1-16 (1971).
35. Sahin, U. et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA 92, 11810-11813 (1995).